RCT | Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes.

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study – The Lancet Endocrinology (link to abstract – $ for full-text)

Commentary: ‘Artificial Pancreas’ Best in Poorly Controlled Type 1 Diabetes – Medscape (free registration required)

Commentary on Twitter

New—Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 #diabetes (ADAPT): a randomised controlled study https://t.co/XrrmoDuQLy #T1D pic.twitter.com/GSLWA3xX7F

— The Lancet Diabetes & Endocrinology (@TheLancetEndo) September 2, 2022